Eylea

Medicinal product

(Invented) name

Eylea

Active substance (s)

Afliberceptas

Strength

40 mg/ml

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA05, Aflibercept

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2012-11-22

Date of renewal

Documents

Eylea mokomoji med_iaga pacientams.pdf

Eylea mokomoji medziaga sveikatos prieziuros specialistams.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled syringe	1 ml
Afliberceptas	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107274	93378	1093378	užpildytas švirkštas	N1		Receptinis	EU/1/12/797/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2012-11-22	Registruotas